Literature DB >> 15801958

Risks factors for highly unstable response to oral anticoagulation: a case-control study.

Gualtiero Palareti1, Cristina Legnani, Giuliana Guazzaloca, Valdré Lelia, Benilde Cosmi, Barbara Lunghi, Giovanna Marchetti, Daniela Poli, Vittorio Pengo.   

Abstract

The factors associated with persistent instability of oral anticoagulant treatment (OAT) were investigated in a case-control study. The most unstable patients from 35 Italian anticoagulation clinics were matched with stable controls, for gender, age and OAT indication. Socio-demographic data, medical history, dietary and life habits, cytochrome P450 CYP2C9 variants, blood cell count, liver and renal functions were investigated. An 'Abbreviated Mental Test' (AMT) and a questionnaire to assess patient compliance to, and comprehension of, OAT indications and mechanisms were administered. An International Normalized Ratio (INR) above 4.5 was more frequently found in cases (n = 77) than controls (n = 80) (12.3% vs. 0.4%; P < 0.0001). The odds ratio for instability was significantly higher for: people who worked versus pensioners, acenocoumarol versus warfarin, and an insufficient score in the AMT and/or in the questionnaire. Cytochrome P450 CYP2C9 variants *1/*3 or *2/*3 or *3/*3 were more frequent among cases than controls (29.9% vs.15.0%; P = 0.042). No differences were observed as regards the other variables. In conclusion, we found that high intra-individual variability in OAT control was multifactorial, but poor OAT comprehension was prevalent.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15801958     DOI: 10.1111/j.1365-2141.2005.05417.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  26 in total

1.  Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy.

Authors:  Andrea Rubboli; Cecilia Becattini; Freek Wa Verheugt
Journal:  World J Cardiol       Date:  2011-11-26

Review 2.  Optimizing quality care for the oral vitamin K antagonists (VKAs).

Authors:  Vittorio Pengo; Gentian Denas
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

3.  A "two-step" educational approach for patients taking oral anticoagulants does not improve therapy control.

Authors:  Doris Barcellona; Paolo Contu; Francesco Marongiu
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

Review 4.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

5.  Use of vitamin K antagonist therapy in geriatrics: a French national survey from the French Society of Geriatrics and Gerontology (SFGG).

Authors:  Matthieu Plichart; Gilles Berrut; Nathalie Maubourguet; Claude Jeandel; Jean-Paul Emeriau; Joël Ankri; Hélène Bouvier; Geneviève Ruault; Olivier Hanon
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

6.  EDUC'AVK: reduction of oral anticoagulant-related adverse events after patient education: a prospective multicenter open randomized study.

Authors:  Gilles Pernod; José Labarère; Jacqueline Yver; Bernadette Satger; Benoit Allenet; Touffek Berremili; Michèle Fontaine; Guy Franco; Jean Luc Bosson
Journal:  J Gen Intern Med       Date:  2008-06-20       Impact factor: 5.128

7.  Predictors of unstable anticoagulation in African Americans.

Authors:  Larisa H Cavallari; Jonathan L Aston; Kathryn M Momary; Nancy L Shapiro; Shitalben R Patel; Edith A Nutescu
Journal:  J Thromb Thrombolysis       Date:  2008-06-19       Impact factor: 2.300

8.  Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.

Authors:  Patrick P Kneeland; Margaret C Fang
Journal:  Patient Prefer Adherence       Date:  2010-03-24       Impact factor: 2.711

9.  Risk factors for nonadherence to warfarin: results from the IN-RANGE study.

Authors:  Alec B Platt; A Russell Localio; Colleen M Brensinger; Dean G Cruess; Jason D Christie; Robert Gross; Catherine S Parker; Maureen Price; Joshua P Metlay; Abigail Cohen; Craig W Newcomb; Brian L Strom; Mitchell S Laskin; Stephen E Kimmel
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-09       Impact factor: 2.890

10.  Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics.

Authors:  Dean G Cruess; A Russell Localio; Alec B Platt; Colleen M Brensinger; Jason D Christie; Robert Gross; Catherine S Parker; Maureen Price; Joshua P Metlay; Abigail Cohen; Craig W Newcomb; Brian L Strom; Stephen E Kimmel
Journal:  Int J Behav Med       Date:  2010-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.